Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Point Of Care Infectious Disease Testing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Point Of Care Infectious Disease Testing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Point Of Care Infectious Disease Testing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Point Of Care Infectious Disease Testing products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Point Of Care Infectious Disease Testing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Point Of Care Infectious Disease Testing market.
To learn more about this report
Increasing research and development spending on Point Of Care Infectious Disease Testing development has been the leading industry trend of Point Of Care Infectious Disease Testing market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Other infectious disease POC |
| By Application Outlook | Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., and Ortho-Clinical Diagnostics. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Point Of Care Infectious Disease Testing Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Point Of Care Infectious Disease Testing Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Point Of Care Infectious Disease Testing Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Point Of Care Infectious Disease Testing Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 HIV POC
4.2.2 Clostridium difficile POC
4.2.3 HBV POC
4.2.4 Pneumonia or Streptococcus associated infections
4.2.5 Respiratory syncytial virus (RSV) POC
4.2.6 HPV POC
4.2.7 Influenza/Flu POC
4.2.8 HCV POC
4.2.9 MRSA POC
4.2.10 TB and drug-resistant TB POC
4.2.11 HSV (Herpes Simplex Virus) POC
4.2.12 Other infectious disease POC
4.4 Type Comparison Matrix
4.5 Global Point Of Care Infectious Disease Testing Market Attractiveness, By Type
5 Global Point Of Care Infectious Disease Testing Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Point Of Care Infectious Disease Testing Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Home
5.3.4 Assisted Living Healthcare Facilities
5.3.5 Laboratories
5.3.6 Others
5.4 Application Comparison Matrix
5.5 Global Point Of Care Infectious Disease Testing Market Attractiveness, by Application
6 Global Point Of Care Infectious Disease Testing Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Point Of Care Infectious Disease Testing Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Point Of Care Infectious Disease Testing Market Attractiveness, by Region
8 North America Point Of Care Infectious Disease Testing Market Analysis and Forecast
8.1 Key Findings
8.2 North America Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 HIV POC
8.2.2 Clostridium difficile POC
8.2.3 HBV POC
8.2.4 Pneumonia or Streptococcus associated infections
8.2.5 Respiratory syncytial virus (RSV) POC
8.2.6 HPV POC
8.2.7 Influenza/Flu POC
8.2.8 HCV POC
8.2.9 MRSA POC
8.2.10 TB and drug-resistant TB POC
8.2.11 HSV (Herpes Simplex Virus) POC
8.2.12 Other infectious disease POC
8.3 North America Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Home
8.3.4 Assisted Living Healthcare Facilities
8.3.5 Laboratories
8.3.6 Others
8.4 North America Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Point Of Care Infectious Disease Testing Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Point Of Care Infectious Disease Testing Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 HIV POC
9.2.2 Clostridium difficile POC
9.2.3 HBV POC
9.2.4 Pneumonia or Streptococcus associated infections
9.2.5 Respiratory syncytial virus (RSV) POC
9.2.6 HPV POC
9.2.7 Influenza/Flu POC
9.2.8 HCV POC
9.2.9 MRSA POC
9.2.10 TB and drug-resistant TB POC
9.2.11 HSV (Herpes Simplex Virus) POC
9.2.12 Other infectious disease POC
9.3 Europe Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Home
9.3.4 Assisted Living Healthcare Facilities
9.3.5 Laboratories
9.3.6 Others
9.4 Europe Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Point Of Care Infectious Disease Testing Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Point Of Care Infectious Disease Testing Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 HIV POC
10.2.2 Clostridium difficile POC
10.2.3 HBV POC
10.2.4 Pneumonia or Streptococcus associated infections
10.2.5 Respiratory syncytial virus (RSV) POC
10.2.6 HPV POC
10.2.7 Influenza/Flu POC
10.2.8 HCV POC
10.2.9 MRSA POC
10.2.10 TB and drug-resistant TB POC
10.2.11 HSV (Herpes Simplex Virus) POC
10.2.12 Other infectious disease POC
10.3 Asia Pacific Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Hospitals
10.3.2 Clinics
10.3.3 Home
10.3.4 Assisted Living Healthcare Facilities
10.3.5 Laboratories
10.3.6 Others
10.4 Asia Pacific Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Point Of Care Infectious Disease Testing Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Point Of Care Infectious Disease Testing Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 HIV POC
11.2.2 Clostridium difficile POC
11.2.3 HBV POC
11.2.4 Pneumonia or Streptococcus associated infections
11.2.5 Respiratory syncytial virus (RSV) POC
11.2.6 HPV POC
11.2.7 Influenza/Flu POC
11.2.8 HCV POC
11.2.9 MRSA POC
11.2.10 TB and drug-resistant TB POC
11.2.11 HSV (Herpes Simplex Virus) POC
11.2.12 Other infectious disease POC
11.3 Latin America Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Hospitals
11.3.2 Clinics
11.3.3 Home
11.3.4 Assisted Living Healthcare Facilities
11.3.5 Laboratories
11.3.6 Others
11.4 Latin America Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Point Of Care Infectious Disease Testing Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Point Of Care Infectious Disease Testing Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 HIV POC
12.2.2 Clostridium difficile POC
12.2.3 HBV POC
12.2.4 Pneumonia or Streptococcus associated infections
12.2.5 Respiratory syncytial virus (RSV) POC
12.2.6 HPV POC
12.2.7 Influenza/Flu POC
12.2.8 HCV POC
12.2.9 MRSA POC
12.2.10 TB and drug-resistant TB POC
12.2.11 HSV (Herpes Simplex Virus) POC
12.2.12 Other infectious disease POC
12.3 Middle East & Africa (MEA) Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Hospitals
12.3.2 Clinics
12.3.3 Home
12.3.4 Assisted Living Healthcare Facilities
12.3.5 Laboratories
12.3.6 Others
12.4 Middle East & Africa (MEA) Point Of Care Infectious Disease Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Point Of Care Infectious Disease Testing Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Alere
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Thermo Fisher Scientific Inc
13.3.3 F. Hoffmann-La Roche Ltd
13.3.4 Siemens Healthineers
13.3.5 BD & Company
13.3.6 Chembio Diagnostics Inc.
13.3.7 Trinity Biotech
13.3.8 Cardinal Health
13.3.9 Quest Diagnostics Inc.
13.3.10 Bio-Rad Labs Inc.
13.3.11 bioMérieux SA
13.3.12 Sight Diagnostics Ltd.
13.3.13 Gene POC
13.3.14 Trivitron Healthcare
13.3.15 OJ-Bio Ltd.
13.3.16 and Ortho-Clinical Diagnostics.
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
